Top Qs
Timeline
Chat
Perspective
PRC200-SS
Triple reuptake inhibitor investigated by the Mayo Clinic From Wikipedia, the free encyclopedia
Remove ads
PRC200-SS is an experimental drug of the triple reuptake inhibitor class that was investigated by the Mayo Clinic.[1][2]
Preclinical toxicology studies of PRC200-SS in cynomolgus monkeys showed dose proportional kidney toxicity,[3] precluding any further drug development.
Remove ads
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads